logo

Aveo Pharmaceuticals, Inc. (AVEO)



Trade AVEO now with
  Date
  Headline
12/12/2018 7:11:03 AM AVEO Oncology Announces Immuno-Oncology Clinical Collaboration With AstraZeneca
11/9/2018 7:13:02 AM AVEO Oncology Q3 Net Loss $22.2 Mln Or $0.18/shr Vs. Net Loss $26.4 Mln Or $0.22/shr Last Year
10/22/2018 7:08:06 AM AVEO Oncology, EUSA Pharma Announce Updated Interim Results From Phase 2 Portion Of TiNivo Study
10/1/2018 7:14:49 AM AVEO Oncology Begins Topline Analysis Of Phase 3 TIVO-3 Trial
8/17/2018 9:11:47 AM AVEO Pharmace Prices Public Offering Of 2.50 Mln Shares At $2.26/shr
7/19/2018 6:34:42 AM AVEO Oncology Expects To Report Topline Results From TIVO-3 Study In Q4
5/8/2018 7:12:36 AM AVEO Oncology Q1 Net Loss $9.0 Mln Or $0.08/shr Vs. Net Loss $8.8 Mln Or $0.12/shr Last Year
3/13/2018 7:16:21 AM AVEO Oncology FY Net Loss $65.0 Mln Or $0.61/Shr Vs Loss Of $26.9 Mln Or $0.39/Shr Last Year
3/13/2018 7:15:33 AM AVEO Oncology 2017 Total Collaboration Revenue $7.6 Mln Vs $2.5 Mln Last Year
2/12/2018 7:07:10 AM AVEO Announces EUSA Pharma Granted Positive NICE Recommendation For FOTIVDA As First Line Treatment For ARCC